The current C43 market cap is 967.48M. The company's latest EPS is EUR -0.3033 and P/E is -207.02.
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 63.25M | 66.8M | 65.89M | 103.99M | 94.23M |
Operating Income | -17.37M | 1.96M | 28.3M | 28.06M | 6.15M |
Net Income | -24.42M | -7.9M | 21.67M | 17.23M | -4.93M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 585.16M | 596.16M | 805.56M | 759.59M | 553.98M |
Total Liabilities | 191.43M | 196.04M | 292.88M | 295.8M | 124.94M |
Total Equity | 393.73M | 400.13M | 512.68M | 463.79M | 429.04M |
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Operating | -18.85M | 12.99M | 12.61M | 33.23M | 33.62M |
Investing | -48.69M | 75.45M | 24.86M | 1.69M | 42.3M |
Financing | -34.46M | -11.88M | -27.25M | -46.13M | -211.27M |
Market Cap | 967.48M |
Price to Earnings Ratio | -207.02 |
Price to Sales Ratio | 10.83 |
Price to Cash Ratio | 20.31 |
Price to Book Ratio | 2.38 |
Dividend Yield | 3.45% |
Shares Outstanding | 16.26M |
Average Volume (1 week) | 59 |
Average Volume (1 Month) | 130 |
52 Week Change | -13.77% |
52 Week High | 87.00 |
52 Week Low | 53.00 |
Spread (Intraday) | 1 (1.67%) |
Company Name | COSMO Pharmaceuticals NV |
Address |
riverside ii dublin 20020 |
Website | https://www.cosmopharmaceuticals.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions